The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications.
Hassfjell
S
S
Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bldg. 10, Room B3B69, Bethesda, MD 20892-1002, USA.
Brechbiel
M W
MW
D000512:Alpha Particles; D000818:Animals; D001729:Bismuth / Q000737:chemistry*; D002614:Chelating Agents; D006801:Humans; D011868:Radioisotopes; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D011878:Radiotherapy
D002614:Chelating Agents; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D001729:Bismuth